Lonza CEO Pierre-Alain Ruffieux to Leave
Lonza CEO Pierre-Alain Ruffieux to Leave
Read more
Tag: Biopharmaceuticals
Nvidia, AMD, AeroVironment, Micron, and More Stock Market Movers
Text size A report said the Commerce Department could stop the shipments of artificial intelligence chips made by Nvidia and ...
Read more
Horizon Therapeutics Stock Plunges on Experiences FTC Will Sue to Block Amgen Offer
Textual content dimension Amgen had aid it envisioned its acquisition of Horizon Therapeutics to be finished in the initial half ...
Read more
Healthcare Stocks Are on Sale. Pfizer and Stryker Have Potent Growth Potential customers.
Health care Stocks Are on Sale. Pfizer and Stryker Have Sturdy Progress Prospective buyers.
Read more
Prometheus, Merck, Moderna, Charles Schwab, XPeng, and Far more Inventory Market Movers
Text dimension Merck agreed to buy Prometheus Biosciences for about $10.8 billion. Michael Vi/Dreamstime Inventory futures have been soaring modestly ...
Read more
Merck to Acquire Prometheus Biosciences
Merck to Purchase Prometheus Biosciences
Read more
Costco, Lumentum, AbbVie, FedEx, and Far more Stock Industry Movers
Text sizing Costco said identical-retailer income declined 1.1% in March. Joe Raedle/Getty Illustrations or photos Inventory futures have been flat ...
Read more
Seagen, Li Car, Union Pacific, Berkshire Hathaway, and Extra Stock Market place Movers
Text measurement Li Vehicle said it expects initially-quarter deliveries to surge. Qilai Shen/Bloomberg Inventory futures rose Monday subsequent the worst ...
Read more
What investors have to have to know about Pfizer’s latest downgrade
Pfizer’s PFE, -.92% early-stage pipeline, even though promising, is continue to also premature to make up for the looming loss ...
Read more
CureVac Stock Just Bought Upgraded. It is Now a Competitor in mRNA Vaccines.
Textual content sizing CureVac inventory has surged given that reporting promising mRNA trial information on Jan. 6. Jeroen Jumelet/ANP/AFP through ...
Read more
